CEL SCI CORP
SC 13E4/A, 1998-01-27
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CEL SCI CORP, 424B3, 1998-01-27
Next: ANGSTROM TECHNOLOGIES INC, 10KSB40, 1998-01-27





                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 SCHEDULE 13E-4

                          Issuer Tender Offer Statement
                Pursuant to Section l3(e)(l) of the Securities
                              Exchange Act of l934

                                (Amendment No. 1)


                               CEL-SCI CORPORATION
                                (Name of Issuer)

                               CEL-SCI CORPORATION
                      (Name of Person(s) Filing Statement)

                         Common Stock Purchase Warrants
                         (Title of Class of Securities)

                                   150-837-128
                      (CUSIP Number of Class of Securities)

                              William T. Hart, Esq.
                                  Hart & Trinen
                             l624 Washington Street
                             Denver, Colorado 80203
                                  303-839-006l
                 (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications
                 on Behalf of the Person(s) Filing Statement)

                                November 14, l997
                      (Date Tender Offer First Published,
                      Sent or Given to Security Holders)




                           Calculation of Filing Fee:

                 ----------------------------------------------
                (                     )                        )
                (   Transaction       )  Amount of Filing Fee  )
                (    Valuation*       )         $4,960         )
                (   $24,800,000       )                        )
                 ----------------------------------------------
<PAGE>

    The  valuation  set  forth  above is  based  upon  the  market  price of the
Warrants, assuming all Warrants are tendered pursuant to this offering.

    *Set forth the amount on which the filing fee is  calculated  and state how
it was determined.

    [X]  Check  box if any  part  of the  fee is  offset  as  provided  by  Rule
0-ll(a)(2)  and identify the filing with which the offsetting fee was previously
paid.  Identify the previous filing by registration  state- ment number,  or the
Form or Schedule and the date of its filing.

    Amounts Previously Paid:  $8,567
    Form or Registration Nos.:   333-31489
    Filing Party:    CEL-SCI Corporation
    Dates Filed:    August 4, l997

Item l.  Security and Issuer

              (a) The name of the issuer is CEL-SCI Corporation.  The address of
its principal executive office is 66 Canal Center Plaza, Suite 510,  Alexandria,
Virginia 22314.

              (b) This  offer  relates to the  issuer's  Common  Stock  Purchase
Warrants (the "Warrants"), of which 5,175,000 Warrants are outstanding as of the
date hereof.  A Warrant  holder who tenders five Warrants and $6.00 in cash will
receive one share of the  issuer's  common  stock (the  "Common  Stock") and one
Series  A  Warrant.  Warrants  may  be  acquired  from  officers,  directors  or
affiliates of the issuer.

              (c)  Incorporated  by  reference  to that  portion of the issuer's
Registration  Statement on Form S-3, SEC File No.  333-31489 (the  "Registration
Statement") captioned "Market for the Company's Common Stock."

              (d) Not applicable.

Item 2.  Source and Amount of Funds or Other Consideration.

         (a)  See Item l(b) above.
         (b)  Not applicable.

Item     3. Purposes of the Tender Offer and Plans or Proposals of the Issuer or
         Affiliate.

         Incorporated  by  reference  to  those  portions  of  the  Registration
Statement captioned "Plan of Distribution - Exchange Offer."

Item 4.  Interest in Securities of the Issuer.

         None.

<PAGE>

Item 5.  Contracts, Arrangements, Understandings or Relationships with Respect
to the Issuer's Securities.

         None.

Item 6.  Persons Retained, Employed or to be Compensated.

         None.

Item 7.  Financial Information.

              (a)   Incorporated   by  reference   to  those   portions  of  the
Registration Statement captioned "Prospectus Summary".

              (b) Not applicable.

Item 8.  Additional Information.

         None.

Item 9.  Material to be Filed as Exhibits.

              (a)  Letter of Transmittal.  See also (e) below.

              (b)  None.

              (c)  None.

              (d)  None.

              (e) Prospectus  filed as part of a Registration  Statement on Form
S-3, Registration Number 333-31489. (Previously filed)

                   Prospectus supplement dated January 27, 1998

              (f)  None.


                                    Signature

         After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

                                       CEL-SCI CORPORATION

January 27, 1998                  By: /s/ Geert R. Kersten
                                      --------------------
                                            Geert R. Kersten
                                            Chief Executive Officer




                                                                       424(b)(3)
                                                    Commission File #: 333-31489

                               CEL-SCI CORPORATION

                            Notice of change to terms
                            for exercise of Warrants


         By means of a  Prospectus  dated  November  14, 1997 the holders of the
Company's  outstanding Warrants were given the opportunity,  at any time between
January 9, 1998 and  February  6, 1998 to  purchase  one share of the  Company's
Common  Stock and one Series A Warrant  for $6.00 (the  "Exchange  Offer").  The
Series A Warrant,  by its  original  terms,  allowed the holder to purchase  one
additional  share of the Company's  Common Stock for $18.00 at any time prior to
February 7, 2000.

         The  terms  of the  offering  made by means of the  November  14,  1997
Prospectus have been changed as follows:

    1. The  exercise  price of the Series A Warrant has been lowered from $18.00
to $10.00.

    2. The  Expiration  Date of the Exchange Offer has been extended to February
17, 1998.

    3. Warrants not exercised by February 17, 1998 may still be exercised at any
time prior to March 7, 1998. Holders exercising Warrants after February 17, 1998
and before March 7, 1998 will  receive,  for $6.00,  one share of the  Company's
common stock. However,  holders exercising Warrants after February 17, 1998 will
not receive a Series A Warrant.

         Warrant holders who exercised  their warrants  subsequent to January 9,
1998 will receive a Series A Warrant exercisable at $10.00 per share.

         The date of this Prospectus Supplement is January 27, 1998.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission